December 23, 2024

Trump Team Targets Immediate WHO Exit, Experts Say

"I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration."

Reuters

December 12, 2024

Key Genetic Variants in Palmoplantar Keratoderma

In a Danish cohort of 142 patients with palmoplantar keratoderma, researchers identified DSP variants linked to cardiomyopathy risk in seemingly typical cases, highlighting why genetic testing matters beyond just diagnosis.

Conexiant

December 09, 2024

Reduced Infection Rates with Long-Term Dupilumab in Kids

A recent study reveals that dupilumab can reduce infection rates in young children with moderate-to-severe atopic dermatitis, offering potential long-term benefits for this patient population.

Conexiant

December 09, 2024

AI, AR & Social Media Transform Cosmetic Dermatology

Learn how AI and AR technologies are reshaping cosmetic dermatology and the impact of social media platforms on beauty standards.

Conexiant

November 26, 2024

Moisturizers in Dermatitis: Risk vs Reward

A recent review finds that moisturizers, commonly used in dermatitis care, may lead to adverse effects in children with eczema, emphasizing the need for moderation and personalized recommendations for their use. Published in the Journal of the American Academy of Dermatology.

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

July 02, 2024

Black Docs Lacking Amid Growing Attacks on Diversity Programs

Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.

KFF Health News

June 06, 2024

Advances in Corneal Transplant Techniques

Explore new techniques in corneal transplantation, including Descemet’s membrane endothelial keratoplasty and artificial corneas, for treating corneal diseases.

Conexiant

June 10, 2024

Oral Sebetralstat Shows Efficacy in Treating HAE Attacks

Phase 3 trial shows oral sebetralstat significantly improves symptom relief and attack resolution in hereditary angioedema patients.

Conexiant